Summary
Axon Enterprise's shares tumbled after its second-quarter 2026 results, with mid-day trading showing a 13.4% drop to $528.12 that extended a sharp after-hours selloff. The company posted revenue of $904.3 million, a 35% increase from the prior year and above the roughly $876.5 million Wall Street estimate, while adjusted earnings per share came in at $1.88, beating the $1.83 consensus. Management raised full-year 2026 revenue growth guidance to 32-34%, up from the prior 30-32% outlook. Even so, the stock swung lower as investors zeroed in on weakening margin metrics, a GAAP net income decline and inventory accumulation.
Quarterly results and guidance
Axon reported second-quarter revenue of $904.3 million, marking a 35% year-over-year increase and outpacing the roughly $876.5 million analysts had forecast. Adjusted EPS was $1.88 versus the consensus of $1.83. Management updated its full-year revenue growth projection to a range of 32-34%, higher than the previously guided 30-32%.
Profitability and balance-sheet signals that spooked investors
Despite top-line strength, the headline investor concern was margin deterioration. Adjusted gross margin within the software and services segment fell to 75.1% from 78.9% in the prior year. Company commentary attributed the decline to a higher mix of professional services revenue and the scaling of newer product lines. Separately, GAAP net income declined year-over-year, and inventory continued to build on the balance sheet. These developments gained outsized attention given the stock had been trading at roughly 244 times earnings ahead of the print.
Street reaction and analyst moves
Some sell-side firms remained constructive on the longer-term case. Goldman Sachs raised its price target to $715, while Piper Sandler increased its target to $732 and kept an Overweight rating on the shares. Those revised targets signaled that parts of the sell-side still see upside, but the analyst upgrades were not enough to halt the broader selling pressure that followed the report.
Market backdrop
The wider U.S. equity market offered limited support. The S&P 500 was down 0.25%, the Dow Jones Industrial Average fell 0.8%, and the Nasdaq Composite slipped 0.1%, producing a mildly risk-off tone that compounded Axon-specific selling. Axon’s high-growth, high-multiple profile makes it especially sensitive to any indications that profitability may not expand in step with revenue growth - a characteristic that has pressured similar software-oriented names during 2026.
Valuation and market recalibration
The sharp post-earnings drop reflects a classic sell-the-news response for a premium-valued growth company: a quarter that beat estimates and a raised guidance range were insufficient to satisfy investors who had priced in near-perfect execution. Any signs of cost pressure or margin slippage were met with an outsized market reaction. After the move, the stock traded notably below its 52-week high of $885 but remained above its 52-week low of $339.01, suggesting the market is re-evaluating how quickly Axon’s revenue gains will convert into sustained profitability.
Bottom line
Axon's latest quarter delivered strong revenue growth and slightly better-than-expected adjusted EPS, along with an upgraded revenue growth outlook for the year. However, weaker software and services margins, a year-over-year decline in GAAP net income, and inventory accumulation sparked heavy selling, outweighing analyst price-target increases and prompting investors to reassess near-term profitability expectations.